{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "cfres_id": "26532",
      "product_res_number": "Z-0719-03",
      "event_date_initiated": "2003-02-24",
      "event_date_posted": "2003-04-10",
      "recall_status": "Terminated",
      "event_date_terminated": "2004-07-23",
      "res_event_number": "25819",
      "product_code": "MIE",
      "product_description": "CryoValve Allograft, Heart valve.",
      "code_info": "Aortic Valve & Conduit, Donor #29976, Serial #6212891, Model #AV00 and Pulmonary Valve & Conduit Donor #51562, Serial #7093095, Model #PV00",
      "firm_fei_number": "3001451326",
      "recalling_firm": "Cryolife Inc",
      "address_1": "1655 Roberts Blvd Nw",
      "city": "Kennesaw",
      "state": "GA",
      "postal_code": "30144",
      "additional_info_contact": "Shari L. Allen\n770-419-3355",
      "reason_for_recall": "Pre-processing cultures detected certain microorganisms in donor tissue.",
      "root_cause_description": "Other",
      "action": "Consignees were first notified by telephone on 2/24/2003 with follow up letter on March 6, 2003 and were advised, if the tissue had not yet been implanted, to remove tissue from implantable inventory and place it into quarantine. CryoLife will provide specific instructions for returning the tissue. A stamped, self-addressed postcard was provided to confirm receipt of the notice and to provide information regarding the disposition of the tissue.",
      "product_quantity": "2 individual heart valve allografts.",
      "distribution_pattern": "Heart allografts were distributed to two hospitals in OH and Quebec, Canada.",
      "openfda": {
        "device_name": "Heart-Valve, Allograft",
        "medical_specialty_description": "Unknown",
        "regulation_number": "",
        "device_class": "3"
      }
    }
  ]
}